497 related articles for article (PubMed ID: 26941012)
1. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid.
Liba Z; Kayserova J; Elisak M; Marusic P; Nohejlova H; Hanzalova J; Komarek V; Sediva A
J Neuroinflammation; 2016 Mar; 13(1):55. PubMed ID: 26941012
[TBL] [Abstract][Full Text] [Related]
2. Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis.
Kothur K; Wienholt L; Mohammad SS; Tantsis EM; Pillai S; Britton PN; Jones CA; Angiti RR; Barnes EH; Schlub T; Bandodkar S; Brilot F; Dale RC
PLoS One; 2016; 11(8):e0161656. PubMed ID: 27575749
[TBL] [Abstract][Full Text] [Related]
3. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.
Kothur K; Gill D; Wong M; Mohammad SS; Bandodkar S; Arbunckle S; Wienholt L; Dale RC
Dev Med Child Neurol; 2017 Aug; 59(8):806-814. PubMed ID: 28439892
[TBL] [Abstract][Full Text] [Related]
5. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.
Ma Y; Wang J; Guo S; Meng Z; Ren Y; Xie Y; Wang M
Front Immunol; 2022; 13():1064007. PubMed ID: 36761173
[TBL] [Abstract][Full Text] [Related]
6. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J
PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620
[TBL] [Abstract][Full Text] [Related]
7. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
8. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
Deng B; Liu XN; Li X; Zhang X; Quan C; Chen XJ
J Neuroimmunol; 2017 Apr; 305():84-91. PubMed ID: 28284352
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
[TBL] [Abstract][Full Text] [Related]
10. Higher CSF Levels of NLRP3 Inflammasome Is Associated With Poor Prognosis of Anti-N-methyl-D-Aspartate Receptor Encephalitis.
Peng Y; Liu B; Pei S; Zheng D; Wang Z; Ji T; Pan S; Shen HY; Wang H
Front Immunol; 2019; 10():905. PubMed ID: 31214158
[TBL] [Abstract][Full Text] [Related]
11. High Level of Soluble CD146 In Cerebrospinal Fluid Might be a Biomarker of Severity of Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Li Q; Chen J; Yin M; Zhao J; Lu F; Wang Z; Yu X; Wang S; Zheng D; Wang H
Front Immunol; 2021; 12():680424. PubMed ID: 34220828
[TBL] [Abstract][Full Text] [Related]
12. Identification of cerebrospinal fluid biomarker candidates for anti-N-methyl-D-aspartate receptor encephalitis: High-throughput proteomic investigation.
Li Y; Yang K; Zhang F; Wang J; Shen H; Liu M; Guo J; Wang J
Front Immunol; 2022; 13():971659. PubMed ID: 36389787
[TBL] [Abstract][Full Text] [Related]
13. Cytokine/chemokine elevation during the transition phase from HSV encephalitis to autoimmune anti-NMDA receptor encephalitis.
Omae T; Saito Y; Tsuchie H; Ohno K; Maegaki Y; Sakuma H
Brain Dev; 2018 Apr; 40(4):361-365. PubMed ID: 29277332
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
[TBL] [Abstract][Full Text] [Related]
15. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
16. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
[TBL] [Abstract][Full Text] [Related]
18. Paediatric onset of multiple sclerosis: Analysis of chemokine and cytokine levels in the context of the early clinical course.
Nohejlova H; Kayserova J; Capek V; Toman T; Krsek P; Liba Z
Mult Scler Relat Disord; 2020 Nov; 46():102467. PubMed ID: 32889374
[TBL] [Abstract][Full Text] [Related]
19. Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis.
Zeng C; Chen L; Chen B; Cai Y; Li P; Yan L; Zeng D
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1266-1273. PubMed ID: 30418472
[TBL] [Abstract][Full Text] [Related]
20. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]